Showing results (371-380 of 458) with videos related to
Sort By:
Pageof 46
Plos One|January 25, 2023
Inflated expectations: Rare-variant association analysis using public controlsJung Kim, Danielle M Karyadi, Stephen W Hartley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2019
Promoting Breast Cancer Surveillance: The EMPOWER Study, a Randomized Clinical Trial in the Childhood Cancer Survivor StudyKevin C Oeffinger, Jennifer S Ford, Chaya S Moskowitz, et al.Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Trans-ancestral genetic study of diabetes mellitus risk in survivors of childhood cancer: a report from the St. Jude Lifetime Cohort and the Childhood Cancer Survivor StudyCindy Im, Achal Neupane, Jessica L Baedke, et al.The Lancet. Oncology|May 31, 2025
Contributions of cancer treatment and genetic predisposition to risk of subsequent neoplasms in long-term survivors of childhood cancer: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor StudyAchal Neupane, Qi Liu, Siddhant Taneja, et al.Journal of the National Cancer Institute|March 6, 2024
Health-related quality of life and DNA methylation-based aging biomarkers among survivors of childhood cancerNoel-Marie Plonski, Yue Pan, Cheng Chen, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 19, 2020
Development and validation of an age-scalable cardiac model with substructures for dosimetry in late-effects studies of childhood cancer survivorsSuman Shrestha, Aashish C Gupta, James E Bates, et al.JAMA Oncology|June 5, 2025
Body Mass Index, Physical Activity, and Subsequent Neoplasm Risk Among Childhood Cancer SurvivorsLenat Joffe, Sedigheh Mirzaei, Shalini Bhatia, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2021
Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morbidity: A Report From the Childhood Cancer Survivor StudyKevin C Oeffinger, Kayla L Stratton, Melissa M Hudson, et al.Neuro-Oncology|January 14, 2014
Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastomaJames G Gurney, Johnnie K Bass, Arzu Onar-Thomas, et al.Cancer|August 19, 2021
Cardiac remodeling after anthracycline and radiotherapy exposure in adult survivors of childhood cancer: A report from the St Jude Lifetime Cohort StudyJohn L Jefferies, Wojciech M Mazur, Carrie R Howell, et al.Pageof 46